Effect Of Benfotiamine On Advanced Glycation Endproducts And Markers Of Endothelial Dysfunction And Inflammation In Diabetic Nephropathy

Effect None
Trial Design Double blind
Trial Length 1-6 months
Number of Subjects 82
Gender Both Genders
Age Range 45-64, 65+
Body Types Obese
Notes for this study:
900mg (3x300mg) Benfotiamine daily for 12 weeks in diabetics with moderate-high levels of urinary albumin failed to reduce serum or urinary AGEs in a trial where diet was not controlled.